Oncotarget
Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases.The term was introduced in the inaugural Editorial,Introducing Oncotarget.
As of January 1, 2022,Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
SSP 47th Annual Meeting
Post-Publication Promotion
Learn about ourFREE
Impact Journals, LLC is the publisher of Oncotarget:www.impactjournals.com.
Impact Journals is a member of theWellcome Trust List of Compliant Publishers.
Impact Journals is a member of theSociety for Scholarly Publishing.
On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control.This malicious action will be reported to the FBI.
Current Volume
This Month's Popular DOIs
(Crossref resolutions)
| 10.18632/ONCOTARGET.23208 |
| 10.18632/ONCOTARGET.6429 |
| 10.18632/ONCOTARGET.9859 |
| 10.18632/ONCOTARGET.13553 |
| 10.18632/ONCOTARGET.14401 |
| 10.18632/ONCOTARGET.15422 |
| 10.18632/ONCOTARGET.16407 |
| 10.18632/ONCOTARGET.19087 |
Most popular Oncotarget DOIs, measured by the number of times each DOI was successfully resolved.
Most Popular DOIs Published in 2024
(Crossref Data)
Top-10 Most Popular DOIs of 2024
(Crossref Data)
Milestones in Modern Scholarly Publishing
On August 25, 2022, the Office of Science and Technology Policy announced a new government policy legislating the immediate public release of all United States-funded research publications by 2025.Learn more here andhere.
On May 23, 2023, the Council of the European Union adopted conclusions on high-quality, transparent, open, trustworthy, and equitable scholarly publishing. The Council calls for immediate and unrestricted open access to publishing research involving public funds.Learn more.
Oncotarget.org: Blog Posts on
New & Trending Papers
Oncotarget.net: Latest Insights
From Our Authors
September 18, 2018
About The Cover
The cover for issue 73 of Oncotarget features Figure 2, "Benefit of CAD in TZ tumor identification," byGaur, et al.
Table of Contents
News
| Genetic alterations associated with ALTered telomeres |
https://doi.org/10.18632/oncotarget.26111 Jacqueline A. Brosnan-Cashman,Mindy K. Graham, and Christopher M. Heaphy |
| 33739-33740 |
| PDF | How to cite |
Editorial
| Systemic therapy for hepatocellular carcinoma: trial enrichment does not guarantee success |
https://doi.org/10.18632/oncotarget.26052 Leonardo G. Da Fonseca,Maria Reig, and Jordi Bruix |
| 33741-33742 |
| PDF | How to cite |
| Genomic mechanisms of immune evasion in colorectal cancer: from discovery to clinical practice |
https://doi.org/10.18632/oncotarget.26105 Catherine S. Grasso, and Marios Giannakis |
| 33743-33744 |
| PDF | How to cite |
Research Papers
| Nuclear PKM2 promotes the progression of oral squamous cell carcinoma by inducing EMT and post-translationally repressing TGIF2 |
https://doi.org/10.18632/oncotarget.25850 Fumie Tanaka,Shohei Yoshimoto,Kazuhiko Okamura,Tetsuro Ikebe, and Shuichi Hashimoto |
| 33745-33761 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |
| Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer |
https://doi.org/10.18632/oncotarget.26031 Mathilde Guerin,Anthony Gonçalves,Yves Toiron,Emilie Baudelet,Matthieu Pophillat,Samuel Granjeaud,Patrick Fourquet,William Jacot,Carole Tarpin,Renaud Sabatier,Emilie Agavnian,Pascal Finetti,José Adelaide,Daniel Birnbaum,Christophe Ginestier,Emmanuelle Charafe-Jauffret,Patrice Viens,François Bertucci,Jean-Paul Borg, and Luc Camoin |
| 33762-33777 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |
| The close relationship between heparanase and epithelial mesenchymal transition in gastric signet-ring cell adenocarcinoma |
https://doi.org/10.18632/oncotarget.26042 Shahid Shah,Caroline Fourgeaud,Simon Derieux,Shahsoltan Mirshahi,Geneviève Contant,Cynthia Pimpie,Rea Lo Dico,Jeannette Soria,Marc Pocard, and Massoud Mirshahi |
| 33778-33787 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |
| RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastoma |
https://doi.org/10.18632/oncotarget.26082 Sabrina Boyrie,Caroline Delmas,Anthony Lemarié,Vincent Lubrano,Perrine Dahan,Laure Malric,José Luis,Julia Gilhodes,Marie Tosolini,Laetitia Mouly,Maxime Lehmann,Christine Toulas,Elizabeth Cohen-Jonathan Moyal, and Sylvie Monferran |
| 33788-33803 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |
| Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? a multi-center, multi-reader investigation |
https://doi.org/10.18632/oncotarget.26100 Sonia Gaur,Nathan Lay,Stephanie A. Harmon,Sreya Doddakashi,Sherif Mehralivand,Burak Argun,Tristan Barrett,Sandra Bednarova,Rossanno Girometti,Ercan Karaarslan,Ali Riza Kural,Aytekin Oto,Andrei S. Purysko,Tatjana Antic,Cristina Magi-Galluzzi,Yesim Saglican,Stefano Sioletic,Anne Y. Warren,Leonardo Bittencourt,Jurgen J. Fütterer,Rajan T. Gupta,Ismail Kabakus,Yan Mee Law,Daniel J. Margolis,Haytham Shebel,Antonio C. Westphalen,Bradford J. Wood,Peter A. Pinto,Joanna H. Shih,Peter L. Choyke,Ronald M. Summers, and Baris Turkbey |
| 33804-33817 |
| Abstract | PDF | HTML | Supplementary Information | How to cite | Press Release |
| Mitochondria as oncotarget: a comparison between the tetracycline analogs doxycycline and COL-3 |
https://doi.org/10.18632/oncotarget.26107 Margherita Protasoni,Albert M. Kroon, and Jan-Willem Taanman |
| 33818-33831 |
| Abstract | PDF | HTML | How to cite |
| Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells |
https://doi.org/10.18632/oncotarget.26112 Shogo Okazaki,Subaru Shintani,Yuki Hirata,Kentaro Suina,Takashi Semba,Juntaro Yamasaki,Kiyoko Umene,Miyuki Ishikawa,Hideyuki Saya, and Osamu Nagano |
| 33832-33843 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |
| The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model |
https://doi.org/10.18632/oncotarget.26117 Tatsuzo Mizukami,Hirofumi Kamachi,Yuki Fujii,Fumihiko Matsuzawa,Takahiro Einama,Futoshi Kawamata,Nozomi Kobayashi,Yutaka Hatanaka, and Akinobu Taketomi |
| 33844-33852 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |  |
| Toxicity of JQ1 in neuronal derivatives of human umbilical cord mesenchymal stem cells |
https://doi.org/10.18632/oncotarget.26127 Shreeya Bakshi,Christina McKee,Keegan Walker,Christina Brown, and G. Rasul Chaudhry |
| 33853-33864 |
| Abstract | PDF | HTML | How to cite |
Corrections
| Correction: The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth |
https://doi.org/10.18632/oncotarget.26156 Harini Nivarthi,Claire Gordziel,Madeleine Themanns,Nina Kramer,Markus Eberl,Björn Rabe,Michaela Schlederer,Stefan Rose-John,Thomas Knösel,Lukas Kenner,Patricia Freund,Fritz Aberger,Xiaonan Han,Robert Kralovics,Helmut Dolznig,Susanne Jennek,Karlheinz Friedrich, and Richard Moriggl |
| 33865-33865 |
| Correction | PDF | How to cite |
Errata
| Erratum: Drug-Targeted Inhibition of Peroxisome Proliferator-Activated Receptor-gamma Enhances the Chemopreventive Effect of Anti-Estrogen Therapy |
https://doi.org/10.18632/oncotarget.26161 Hongyan Yuan,Levy Kopelovich,Yuzhi Yin,Jin Lu, and Robert I. Glazer |
| 33866-33866 |
| Erratum | PDF | How to cite |
Copyright © 2025 Rapamycin Press LLC dba Impact Journals